characteristics.text: NA
characteristics.characteristic: #units
characteristics.text: 2025-01-08
characteristics.characteristic: ENA first public
characteristics.text: ERC000039
characteristics.characteristic: ENA-CHECKLIST
characteristics.text: CoP
characteristics.characteristic: INSDC center name
characteristics.text: public
characteristics.characteristic: INSDC status
characteristics.text: ERS22624274
characteristics.characteristic: SRA accession
characteristics.text: ena-SAMPLE-TAB-18-12-2024-14:23:22:839-9355
characteristics.characteristic: Submitter Id
characteristics.text: UoG
characteristics.characteristic: collecting institution
characteristics.text: 2023-04-26
characteristics.characteristic: collection date
characteristics.text: GLAS
characteristics.characteristic: collector name
characteristics.text: Sequence from mycATRdc cl1 treated with chronic HU treatment and collected 0 hours after treatment release replicate 2
characteristics.characteristic: description
characteristics.text: procyclic form
characteristics.characteristic: dev_stage
characteristics.text: NA
characteristics.characteristic: genotype
characteristics.text: United Kingdom
characteristics.characteristic: geographic location (country and/or sea)
characteristics.text: NA
characteristics.characteristic: isolate
characteristics.text: Leishmania major
characteristics.characteristic: organism
characteristics.text: Leishmania major
characteristics.characteristic: scientific_name
characteristics.text: LT252
characteristics.characteristic: strain
characteristics.text: GL44_mycATRdc_cl1_chronic_0h_R2
characteristics.characteristic: title